MedicineBiology

C. Röllig

2019.7.9Best Practice Onkologie

DOI: 10.1007/s11654-019-0164-4

tlooto Summary

Allogeneic hematopoietic stem cell transplantation remains the best chance for cure and Cytogenetic anomalies and mutation testing remain important prognostic tools for tailoring treatment after induction therapy.

Abstract

Abstract is not available.

Citation format

RÖLLIG, C. Diagnostik und therapie der akuten myeloischen leukämie. Best Practice Onkologie, 2019: 1–12.